Journal
DRUG DISCOVERY TODAY
Volume 27, Issue 8, Pages 2065-2070Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2022.04.017
Keywords
Medicinal chemistry; Drug discovery; Chemoinformatics; Data science; Data-driven R& Feature; PERSPECTIVE
Categories
Ask authors/readers for more resources
Artificial intelligence and data science are starting to influence drug discovery. A pilot study at Daiichi Sankyo Company has attempted to integrate data science into practical medicinal chemistry and quantify its impact. The results indicate the potential of data-driven medicinal chemistry and suggest new models for training next-generation medicinal chemists.
Artificial intelligence (AI) and data science are beginning to impact drug discovery. It usually takes considerable time and efforts until new scientific concepts or technologies make a transition from conceptual stages to practical applicability and experience values are gathered. Especially for computational approaches, demonstrating measurable impact on drug discovery projects is not a trivial task. A pilot study at Daiichi Sankyo Company has attempted to integrate data science into practical medicinal chemistry and quantify the impact, as reported herein. Although characteristic features and focal points of early-phase drug discovery naturally vary at different pharmaceutical companies, the results of this pilot study indicate significant potential of data-driven medicinal chemistry and suggest new models for internal training of next-generation medicinal chemists
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available